Healthcare provider profile · identity verified

Vijayakumar Alla, M.D

Internal Medicine · ASTORIA, NY · NPI 1598748592

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	225
Amlodipine Besylate	Amlodipine Besylate	544	190
Metformin Hcl	Metformin Hcl	437	162
Losartan Potassium	Losartan Potassium	286	108
Metoprolol Succinate	Metoprolol Succinate	261	93
Levothyroxine Sodium	Levothyroxine Sodium	260	82
Simvastatin	Simvastatin	258	88
Rosuvastatin Calcium	Rosuvastatin Calcium	211	79
Lisinopril	Lisinopril	203	71
Pantoprazole Sodium	Pantoprazole Sodium	186	57
Omeprazole	Omeprazole	182	74
Gabapentin	Gabapentin	175	68
Albuterol Sulfate Hfa	Albuterol Sulfate	170	72
Jardiance	Empagliflozin	159	50
Hydrochlorothiazide	Hydrochlorothiazide	152	50
Januvia	Sitagliptin Phosphate	125	45
Tamsulosin Hcl	Tamsulosin Hcl	123	48
Farxiga	Dapagliflozin Propanediol	110	33
Atenolol	Atenolol	93	33
Montelukast Sodium	Montelukast Sodium	93	36
Clopidogrel	Clopidogrel Bisulfate	92	34
Alendronate Sodium	Alendronate Sodium	87	25
Enalapril Maleate	Enalapril Maleate	85	32
Metformin Hcl Er	Metformin Hcl	79	28
Eliquis	Apixaban	76	20
Metoprolol Tartrate	Metoprolol Tartrate	75	27
Carvedilol	Carvedilol	71	28
Ozempic	Semaglutide	63	17
Glipizide Er	Glipizide	62	23
Alcohol Prep Pads	Alcohol Antiseptic Pads	60	22
Famotidine	Famotidine	56	19
Sertraline Hcl	Sertraline Hcl	55	11
Ezetimibe	Ezetimibe	51	21
Azithromycin	Azithromycin	50	43
Diclofenac Sodium	Diclofenac Sodium	50	22
Pravastatin Sodium	Pravastatin Sodium	50	16
Single Use Swab	Alcohol Antiseptic Pads	47	27
Janumet	Sitagliptin Phos/Metformin Hcl	46	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	17
Furosemide	Furosemide	43	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	15
Tradjenta	Linagliptin	42	suppressed
Breo Ellipta	Fluticasone/Vilanterol	41	11
Finasteride	Finasteride	41	13
Glipizide	Glipizide	41	17
Novolog Flexpen	Insulin Aspart	40	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	14
Folic Acid	Folic Acid	36	16
Meclizine Hcl	Meclizine Hcl	36	22
Azelastine Hcl	Azelastine Hcl	35	15
Vitamin D2	Ergocalciferol (Vitamin D2)	35	14
Trazodone Hcl	Trazodone Hcl	34	15
Linzess	Linaclotide	33	suppressed
Nifedipine Er	Nifedipine	33	11
Donepezil Hcl	Donepezil Hcl	32	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Hydralazine Hcl	Hydralazine Hcl	30	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	29	suppressed
Calcitriol	Calcitriol	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	13
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Ramipril	Ramipril	26	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	23	12
Glipizide-Metformin	Glipizide/Metformin Hcl	23	suppressed
Levemir Flexpen	Insulin Detemir	22	suppressed
Meloxicam	Meloxicam	22	14
Torsemide	Torsemide	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Naproxen	Naproxen	20	13
Valsartan	Valsartan	20	11
Rybelsus	Semaglutide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Unifine Pentips	Pen Needle, Diabetic	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Baclofen	Baclofen	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Glyburide	Glyburide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Prednisone	Prednisone	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Methimazole	Methimazole	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error